The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Renal cell carcinoma
Abstract
PURPOSE OF REVIEW: In this review we will highlight the recent novel contributions to the treatment of renal cell carcinoma in the fields of anti-angiogenesis, immunotherapeutics, and surgical management. In addition, this review will update recent advances in diagnostic and imaging modalities for renal cell carcinoma and dietary and environmental relationships to the epidemiology of this growing disease. RECENT FINDINGS: Advancements in the use of innovative treatment strategies for the management of localized renal cell carcinoma and the introduction of new targeted therapeutics with benefit in the metastatic setting has produced a major impact on the treatment of this disease. SUMMARY: The management of metastatic renal cell carcinoma has undergone a revolution in the past year with groundbreaking treatment strategies encompassing a broad range of therapeutic modalities. At the other end of the spectrum, emerging data is beginning to change our perspective about the management of small, localized renal tumors that are being discovered with increasing frequency. This review will update recent findings supporting diet and tobacco exposure as etiologic factors in the development of renal cell carcinoma, the molecular concepts that underlie the disease and the targeted therapeutics designed to inhibit specific kinase activities, and emerging use of minimally invasive therapies for localized disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–291 of 291
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma
Sandlund, J., Oosterwijk, E., Grankvist, K., Oosterwijk‐Wakka, J. C., Ljungberg, B., & Rasmuson, T. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07006.x · Cited by 114
Long-term Fatty Fish Consumption and Renal Cell Carcinoma Incidence in Women
Wolk, A., Larsson, S. C., Johansson, J.-E., & Ekman, P. (2006) · JAMA · doi:10.1001/jama.296.11.1371 · Cited by 114
van Dijk, B. A. C., Schouten, L. J., Kiemeney, L. A. L. M., Goldbohm, R. A., & van den Brandt, P. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh344 · Cited by 111
A Phase II Trial of Gefitinib (Iressa, ZD1839) in Stage IV and Recurrent Renal Cell Carcinoma
Dawson, N. A., Guo, C., Zak, R. D., Dorsey, B., Smoot, J., Wong, J. K. M., & Hussain, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0310 · Cited by 110
Hypertension, Antihypertensive Medication Use, and Risk of Renal Cell Carcinoma
Shapiro, J. A., Williams, M. A., Weiss, N. S., Stergachis, A. S., LaCroix, A. Z., & Barlow, W. E. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009848 · Cited by 108
Pandha, H., John, R. J., Hutchinson, J. A., James, N. D., Whelan, M., Corbishley, C. M., & Dalgleish, A. G. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.04922.x · Cited by 107
Furge, K. A., Lucas, K. A., Takahashi, M., Sugimura, J., Kort, E. J., Kanayama, H.-O., Kagawa, S., Hoekstra, P., Curry, J., Yang, X. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0534 · Cited by 107
Pseudohypoxic Pathways in Renal Cell Carcinoma
Bratslavsky, G., Sudarshan, S., Neckers, L., & Linehan, W. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2510 · Cited by 103
Diet and risk of renal cell cancer: a population-based case-control study.
Lindblad, P., Wolk, A., Bergström, R., & Adami, H. (1997) · PubMed · Cited by 102
Motzer, R. J., Rakhit, A. K., Ginsberg, M. S., Rittweger, K., Vuky, J., Yu, R., Fettner, S. H., & Hooftman, L. W. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1312 · Cited by 101
On the Road to New Drugs in Acute Myeloid Leukemia
Löwenberg, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6462 · Cited by 101
The pVHL-HIF-1 system: A key mediator of oxygen homeostasis
Maxwell, P., Pugh, C. W., & Ratcliffe, P. J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-3401-0_24 · Cited by 100
Theis, R. P., Grieb, S. M. D., Burr, D. L., Siddiqui, T., & Asal, N. R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-387 · Cited by 100
Mock, H., Sauter, G., Buchholz, N. P. N., Gasser, T. C., Bubendorf, L., Waldman, F., & Mihatsch, M. J. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90198-2 · Cited by 100
Fruits, vegetables and risk of renal cell carcinoma: A prospective study of Swedish women
Rashidkhani, B., Lindblad, P., & Wolk, A. (2004) · International Journal of Cancer · doi:10.1002/ijc.20577 · Cited by 100
Prognostic Models and Algorithms in Renal Cell Carcinoma
Lane, B. R., & Kattan, M. W. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.003 · Cited by 98
Crispen, P. L., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23566 · Cited by 98
Aass, N., Mulder, P. H. M. D., Mickisch, G., Mulders, P., van Oosterom, A. T., van Poppel, H., Fosså, S. D., de Prijck, L., & Sylvester, R. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.114 · Cited by 98
Oosterwijk‐Wakka, J. C., Tiemessen, D. M., Bleumer, I., de Vries, I. J. M., Jongmans, W., Adema, G. J., Debruyne, F. M. J., de Mulder, P. H., Oosterwijk, E., & Mulders, P. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200211000-00006 · Cited by 98
CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer
Höltl, L., Rieser, C., Papesh, C., Ramoner, R. E., Bartsch, G. H., & Thurnher, M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60748-9 · Cited by 96
Dignat‐George, F., Sabatier, F., Blann, A. D., & Woywodt, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.7677 · Cited by 96
Uhlman, D. L., Nguygen, P. L., Manivel, J. C., Aeppli, D. M., Resnick, J. M., Fraley, E. E., Zhang, G., & Niehans, G. A. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.19.1470 · Cited by 94
Grossman, E., Messerli, F. H., & Goldbourt, U. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00021-1 · Cited by 94
Haitel, A., Wiener, H. G., Baethge, U., Marberger, M., & Susani, M. (2000) · PubMed · Cited by 92
Amato, R. J., Harris, P. W., Dalton, M., Khan, M., Alter, R., Zhai, Q. “., Brady, J. R., Jac, J., Hauke, R. J., & Srinivas, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.5026 · Cited by 92
Chemotherapy for renal cell carcinoma.
Hartmann, J. T., & Bokemeyer, C. (1999) · PubMed · Cited by 92
Gitlitz, B. J., Belldegrun, A. S., Zisman, A., Chao, D. H., Pantuck, A. J., Hinkel, A., Mulders, P., Moldawer, N. P., Tso, C.-L., & Figlin, R. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200309000-00004 · Cited by 88
Lee, J. E., Spiegelman, D. L., Hunter, D. J., Albanes, D., Bernstein, L., van den Brandt, P. A., Buring, J. E., Cho, E., English, D. R., Freudenheim, J. L., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn386 · Cited by 88
Tani, K., Azuma, M., Nakazaki, Y., Oyaizu, N., Hase, H., Ohata, J., TAKAHASHI, K. G., Oiwa‐Monna, M., Hanazawa, K., Wakumoto, Y., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.001 · Cited by 86
Webster, W. S., Lohse, C. M., Thompson, R. H., Dong, H., Frigola, X., Dicks, D. L., Sengupta, S., Frank, I., Leibovich, B. C., Blute, M. L., et al. (2006) · Cancer · doi:10.1002/cncr.21951 · Cited by 86
Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas
Hemmerlein, B., Kugler, A., Özisik, R., Ringert, R.-H., Radzun, H., & Thelen, P. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100464 · Cited by 86
Tobacco use in relation to renal cell carcinoma.
Yuan, J., Castelao, J. E., Gago-Domínguez, M., Yu, M. C., & Ross, R. K. (1998) · PubMed · Cited by 86
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
Hedberg, Y., Ljungberg, B., Roos, G., & Landberg, G. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600922 · Cited by 85
Weikert, S., Boeing, H., Pischon, T., Olsen, A., Tjønneland, A. M., Overvad, K., Becker, N., Linseisen, J., Lahmann, P. H., Arvaniti, A., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21765 · Cited by 85
Liu, M. Y., Poellinger, L., & Walker, C. L. (2003) · PubMed · Cited by 83
Hutson, T. E., Davis, I. D., Machiels, J. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.5046 · Cited by 83
Pregnancy and risk of renal cell cancer: a population-based study in Sweden
Lambe, M. P., Lindblad, P., Wuu, J., Remler, R., & Hsieh, C.-C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600263 · Cited by 82
Igarashi, H., Esumi, M., Ishida, H., & Okada, K. (2002) · Cancer · doi:10.1002/cncr.10635 · Cited by 81
Rini, B. I., & Campbell, S. C. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.136 · Cited by 79
Self-citationMolecular Pathways in Renal Cell Carcinoma—Rationale for Targeted Treatment
KIM, W., & KAELINJR, W. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.06.001 · Cited by 79
Alatrash, G., Hutson, T. E., Moltó, L. M., Richmond, A. L., Nemec, C., Mekhail, T. M., Elson, P. J., Tannenbaum, C. S., Olencki, T. E., Finke, J. H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.045 · Cited by 79
Lamb, G. W. A., McMillan, D. C., Ramsey, S., & Aitchison, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603034 · Cited by 78
Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response.
Chakraborty, N. G., Twardzik, D. R., Sivanandham, M., Ergin, M. T., Hellström, K. E., & Mukherji, B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.7.2359 · Cited by 75
Frey, J. R., Peck, R., & Bollag, W. B. (1991) · Cancer Letters · doi:10.1016/0304-3835(91)90161-a · Cited by 75
Neves, A., Ensina, L. F., Anselmo, L. B., Leite, K. R. M., Buzaid, A. C., Camara-Lopes, L. H. A., & Barbuto, J. A. M. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0550-8 · Cited by 74
Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat
Yeung, R. S. W., Xiao, G., Everitt, J. I., Jin, F., & Walker, C. L. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140107 · Cited by 69
Seliger, B., Yang, R., Atkins, D., Hammers, S., Huber, C., Störkel, S., & Kiessling, R. W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000801)87:3<349::aid-ijc7>3.0.co;2-o · Cited by 69
Lara, P. N., Quinn, D. I., Margolin, K. A., Meyers, F. J., Longmate, J., Frankel, P. H., Mack, P. C., Turrell, C., Valk, P. J. M., Rao, J., et al. (2003) · PubMed · Cited by 66
Physical Activity during Adulthood and Adolescence in Relation to Renal Cell Cancer
Moore, S. C., Chow, W., Schatzkin, A. G., Adams, K. F., Park, Y., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn102 · Cited by 64
Gender, Alcohol Consumption, and Renal Cell Carcinoma
Parker, A. S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.5.455 · Cited by 64
Meat intake, 'mate' drinking and renal cell cancer in Uruguay: a case-control study
Stéfani, E. D., Fierro, L., Mendilaharsu, M., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.661 · Cited by 63
Miyake, H., HARA, S., Arakawa, S., Kamidono, S., & Hara, I. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(01)69130-4 · Cited by 62
Ljungberg, B., Landberg, G., & Alamdari, F. I. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750041979 · Cited by 62
Tuberous sclerosis gene products in proliferation control
Hengstschläger, M., Rodman, D. M., Miloloza, A., Hengstschläger-Ottnad, E., Rosner, M., & Kubista, M. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(01)00058-8 · Cited by 61
Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma
Avigan, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-050005 · Cited by 61
Statins Might Reduce Risk of Renal Cell Carcinoma in Humans: Case-Control Study of 500,000 Veterans
Khurana, V., Caldito, G. C., & Ankem, M. K. (2008) · Urology · doi:10.1016/j.urology.2007.08.039 · Cited by 60
van Dijk, B. A. C., Schouten, L. J., Kiemeney, L. A. L. M., Goldbohm, R. A., & van den Brandt, P. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21203 · Cited by 57
Gemmill, R. M., Zhou, M., Costa, L. J., Korch, C. T., Bukowski, R. M., & Drabkin, H. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602646 · Cited by 55
Major Dietary Patterns and Risk of Renal Cell Carcinoma in a Prospective Cohort of Swedish Women
Rashidkhani, B., Åkesson, A., Lindblad, P., & Wolk, A. (2005) · Journal of Nutrition · doi:10.1093/jn/135.7.1757 · Cited by 55
Immunoregulatory T cells in cancer immunotherapy
Morse, M. A., Clay, T. M., Mosca, P. J., & Lyerly, H. K. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.8.827 · Cited by 53
Prognostic factors in renal cell and bladder cancer
Brussel, V., & Mickisch (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00120.x · Cited by 52
Ma, X., Yang, K., Lindblad, P., Egevad, L., & Hemminki, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204692 · Cited by 52
Actuality of Warburg’s views in our understanding of renal cancer metabolism
Godinot, C., de Laplanche, E., Hervouet, É., & Simonnet, H. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9088-8 · Cited by 52
Lam, J. S., Belldegrun, A. S., & Figlin, R. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-sup-040027 · Cited by 52
A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma
Pagliaro, L. C., Daliani, D., Amato, R. J., Tu, S., JONES, D. M., Smith, T., Logothetis, C. J., & Millikan, R. E. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<615::aid-cncr17>3.0.co;2-j · Cited by 50
Active and passive smoking and risk of renal cell carcinoma in Canada
Hu, J., & Ugnat, A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.003 · Cited by 50
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma
Tripathi, R., Heilbrun, L. K., Jain, V., & Vaishampayan, U. N. (2006) · Urology · doi:10.1016/j.urology.2006.02.036 · Cited by 47
Differential gene expression identifies subgroups of renal cell carcinoma
Skubitz, K. M., Zimmerman, W., Kammerer, R., Pambuccian, S. E., & Skubitz, A. P. N. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2006.04.001 · Cited by 46
Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma
Kanayama, H., Lui, W., Takahashi, M., Naroda, T., Kedra, D., Wong, F. K., Kuroki, Y., Nakahori, Y., Larsson, C., Kagawa, S., et al. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.3.165 · Cited by 45
Seliger, B., Menig, M., Lichtenfels, R., Atkins, D., Bukur, J., Halder, T. M., Kersten, M., Harder, A., Ackermann, A., Beck, J., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300404 · Cited by 44
Zhou, X., Jun, D. Y., Thomas, A. M., Huang, X., Huang, L., Mautner, J., Mo, W., Robbins, P. F., Pardoll, D. M., & Jaffee, E. M. (2005) · Cancer Research · doi:10.1158/0008-5472.1079.65.3 · Cited by 43
Body Mass Index and Risk of Renal Cell Carcinoma
Shapiro, J. A., Williams, M. A., & Weiss, N. S. (1999) · Epidemiology · doi:10.1097/00001648-199903000-00019 · Cited by 42
Elaraj, D. M., White, D. E., Steinberg, S. M., Haworth, L. R., Rosenberg, S. A., & Yang, J. C. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200407000-00001 · Cited by 42
Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma
Feldman, D. R., Ginsberg, M. S., Baum, M. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.5100 · Cited by 42
Nyberg, U., Nilsson, B. R., Travis, L. B., Holm, L., & Hall, P. N. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0419:ciaspe]2.0.co;2 · Cited by 40
Spigel, D. R., Hainsworth, J. D., Sosman, J. A., Raefsky, E. L., Meluch, A. A., Edwards, D., Horowitz, P., Thomas, K., Yost, K. J., Stagg, M. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.4540 · Cited by 39
Occupational risk factors for renal cell cancer. An Italian case-control study.
Buzio, L., Tondel, M. O., Palma, G. D., Buzio, C., Franchini, I., Mutti, A., & Axelson, O. (2002) · PubMed · Cited by 34
Expression of Hypoxia Inducible Factor-1α and 2α in Genetically Distinct Early Renal Cortical Tumors
Kim, C. M., Vocke, C. D., Torres-Cabala, C. A., Yang, Y., Schmidt, L. S., Walther, M. M., & Linehan, W. M. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00890-6 · Cited by 33
Motzer, R. J. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00062-3 · Cited by 31
Renal Manifestations of Tuberous Sclerosis Complex
Torres, V. E., Zincke, H., King, B., & Björnsson, J. (1997) · KARGER eBooks · doi:10.1159/000059871 · Cited by 29
Rosenberg, J. E., Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Bukowski, R. M., George, D. J., Kim, S. T., Baum, C. M., & Wilding, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.5095 · Cited by 29
Gabow, P. A., & Bennett, W. M. (1991) · PubMed · Cited by 28
Golshayan, A., Brick, A. J., & Choueiri, T. K. (2008) · Future Oncology · doi:10.2217/14796694.4.1.85 · Cited by 27
Mautner, J., Jaffee, E. M., & Pardoll, D. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20927 · Cited by 25
Cigarette smoking, von Hippel–Lindau gene mutations and sporadic renal cell carcinoma
van Dijk, B. A. C., Schouten, L. J., Oosterwijk, E., de Kaa, C. A. H.-V., Kiemeney, L. A. L. M., Goldbohm, R. A., Schalken, J. A., & van den Brandt, P. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603281 · Cited by 25
Molecular Genetics of Renal Cell Carcinoma
Erlandsson, R. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00384-1 · Cited by 23
Pavlovich, C. P., Padilla‐Nash, H. M., Wangsa, D., Nickerson, M. L., Matrosova, V. Y., Linehan, W. M., Ried, T., & Phillips, J. L. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10209 · Cited by 23
Alcohol drinking and renal cell carcinoma in Canadian men and women
Hu, J., Chen, Y., Mao, Y., DesMeules, M., & Mery, L. (2008) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2008.02.001 · Cited by 23
Alcohol consumption and renal cell cancer risk in two Italian case–control studies
Pelucchi, C., Galeone, C., Montella, M., Polesel, J., Crispo, A., Talamini, R., Negri, E., Ramazzotti, V., Grimaldi, M., Franceschi, S., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm590 · Cited by 22
Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L., & Zincke, H. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000144546.83836.3c · Cited by 4
(2001) · PubMed
Cited by
Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., & Charbonneau, C. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.12.001 · Cited by 974
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929
Chang, Y. S., Adnane, J., Trail, P. A., Levy, J., Henderson, A., Xue, D., Bortolon, E., Ichetovkin, M., Chen, C., McNabola, A., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0393-4 · Cited by 459
Pantuck, A. J., Seligson, D. B., Klatte, T., Yu, H., Leppert, J. T., Moore, L., O'Toole, T., Gibbons, J., Belldegrun, A. S., & Figlin, R. A. (2007) · Cancer · doi:10.1002/cncr.22677 · Cited by 350
Increased cancer risk after liver transplantation: a population-based study
Haagsma, E. B., Hagens, V. E., Schaapveld, M., van den Berg, A. P., de Vries, E. G. E., Klompmaker, I. J., Slooff, M. J. H., & Jansen, P. L. M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00077-5 · Cited by 323
Metadata
- Authors
- Rini, B. I., Campbell, S. C., & Rathmell, W. K.
- Venue
- Current Opinion in Oncology
- Published
- 2006-05
- Volume
- 18
- Issue
- 3
- Pages
- 289-296
- ISSN
- 1040-8746 (ISSN-L)
- OpenAlex
- W2148898638
- Cited by
- 379
- References
- 291
- FWCI
- 22.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.